Kate Gelperin, MD, MPH

Medical Officer
Division of Epidemiology, Office of Pharmacovigilance and Epidemiology, Food and Drug Administration

Presentation(s):

• OP-18C - Effects of Gadolinium-enhanced MRI Exposure During Pregnancy on Neonatal Intensive Care Unit Admission

  Monday, August 23, 2021
  1:45 PM – 3:30 PM US Eastern Time